Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.02. | 4D Molecular Therapeutics, Inc.: 4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD | 237 | GlobeNewswire (Europe) | 51 wet AMD patients with severe disease activity (mean of 442 µm central subfield thickness & presence of retinal fluid) and high treatment burden (mean of 10 anti-VEGF injections in preceding 12... ► Artikel lesen | |
03.02. | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration | 334 | GlobeNewswire (Europe) | Subgroup analyses underscore favorable clinical profile and durability of EYP-1901Presentations highlight previously reported positive Phase 2 DAVIO 2 topline results showing all primary and secondary... ► Artikel lesen | |
03.02. | WUXI BOYU PLASTIC MACHINERY CO., LTD.: Wuxi Boyu Plastic Machinery Showcases the Latest SPC Flooring Innovations at DOMOTEX 2024 | 881 | GlobeNewswire (Europe) | WUXI, China, Feb. 03, 2024 (GLOBE NEWSWIRE) -- Boyu, a renowned brand in the flooring industry, took center stage at DOMOTEX 2024, underlining its position as a leader in SPC flooring manufacturing.... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.683 |
NEL | 1.669 |
SUPER MICRO COMPUTER | 1.660 |
NVIDIA | 1.652 |
TUI | 1.486 |
BAYER | 1.339 |
RHEINMETALL | 1.000 |
RENK GROUP | 932 |
PROSIEBENSAT.1 | 914 |
VOLKSWAGEN | 735 |
AMAZON | 699 |
PALANTIR TECHNOLOGIES | 698 |
TESLA | 687 |
MICROSTRATEGY | 636 |
DEUTSCHE BANK | 586 |
PLUG POWER | 571 |
BASF | 565 |
BYD | 558 |
THYSSENKRUPP | 542 |
COMMERZBANK | 535 |
AIXTRON SE | 533 |
MERCEDES-BENZ | 508 |
SAP | 507 |
ALLIANZ | 495 |
DEUTSCHE TELEKOM | 474 |